Toxicity Due to Chemotherapy
16
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (16)
Impact of Gonadotoxic Therapies on Fertility
Pilot Study of an NTproBNP Guided Strategy of Cardioprotection
Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers
Investigating Cardiovascular Adverse Events Related to Cancer Treatment
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Dose Optimization and Efficacy Assessment of a Fluoropyrimidine Antidote
Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer
Systemic Treatment Related Toxicity Identified With a Smartphone APPlication Measuring Step Count
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Optimized Multi-modality Machine Learning Approach During Cardio-toxic Chemotherapy to Predict Arising Heart Failure
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
Limiting Chemotherapy Side Effects by Using Moxa
Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination
Acupuncture for Chemotherapy-induced Peripheral Neuropathy
Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer